| CKD end-stage (n = 5) | Not CKD end-stage (n = 44) | P |
Age Sex-ratio Delay between early symptomatology and start of treatment greater than 3 months Hypertension Mean serum creatinine Renal insufficiency Anemia Lymphopenia C3 Hypocomplementemia CH50 Hypocomplementemia Anti-ENA Anti-dsDNA Mean proteinuria Nephrotic syndrome Microscopic hematuria Leukocyturia | 40.5 ± 5.2 2H/3F 1 cas (20%)
3 cas (60%) 56.7 ± 12.1 5 cas (100%) 5 cas (100%) 1 cas (20%) 0 cas (0%) 0 cas (%) 1 cas (20%) 1 cas (20%) 3 cas (60%) 3.3 ± 2.6 3 cas (60%) 2 cas (40%) | 31.6 ± 8.9 9H/35F 9 cas (20.45%)
9 cas (20.45%) 19.2 ± 9.9 14 cas (31.81%) 38 cas (86.36%) 6 cas (13.63%) 1 cas (2.27%) 1 cas (2.27%) 19 cas (43.18%) 7 cas (15.90%) 24 cas (54.54%) 3.2 ± 2.6 15 cas (34.09%) 13 cas (29.54%) | 0.555 0.396 0.239
0.091 0.785 0.718 0.366 0.615 0.448 0.446 0.854 0.041 0.717 0.594 0.017 0.019 |